buddlejasaponin iv has been researched along with ascorbic acid in 1 studies
| Studies (buddlejasaponin iv) | Trials (buddlejasaponin iv) | Recent Studies (post-2010) (buddlejasaponin iv) | Studies (ascorbic acid) | Trials (ascorbic acid) | Recent Studies (post-2010) (ascorbic acid) |
|---|---|---|---|---|---|
| 9 | 0 | 4 | 45,261 | 2,497 | 11,176 |
| Protein | Taxonomy | buddlejasaponin iv (IC50) | ascorbic acid (IC50) |
|---|---|---|---|
| Chain A, Hyaluronidase, phage associated | Streptococcus pyogenes | 1000 | |
| Urease | Canavalia ensiformis (jack bean) | 8.59 | |
| Solute carrier family 23 member 1 | Homo sapiens (human) | 156 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonesi, M; Conforti, F; Deguin, B; Loizzo, MR; Menichini, F; Tillequin, F; Tundis, R | 1 |
1 other study(ies) available for buddlejasaponin iv and ascorbic acid
| Article | Year |
|---|---|
Cytotoxic activity and inhibitory effect on nitric oxide production of triterpene saponins from the roots of Physospermum verticillatum (Waldst & Kit) (Apiaceae).
Topics: Animals; Antineoplastic Agents, Phytogenic; Apiaceae; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Humans; Macrophages; Mice; Neoplasms; Nitric Oxide; Oleanolic Acid; Plant Roots; Saponins; Triterpenes | 2009 |